Cleo Diagnostics Ltd
- Country
- 🇨🇦Canada
- Ownership
- -
- Employees
- 72
- Market Cap
- -
- Introduction
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
- Conditions
- Ovarian Neoplasms
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Cleo Diagnostics Ltd
- Target Recruit Count
- 1000
- Registration Number
- NCT06566716
- Locations
- 🇺🇸
New Horizons Clinical Trials, Chandler, Arizona, United States
🇺🇸Emerald Coast Clinical Research, Panama City, Florida, United States
🇺🇸Women's Cancer Center of Nevada, Las Vegas, Nevada, United States